valproic acid has been researched along with Lung Adenocarcinoma in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatziantoniou, A | 1 |
| Zaravinos, A | 1 |
| Ding, S | 1 |
| Pickard, AJ | 1 |
| Kucera, GL | 1 |
| Bierbach, U | 1 |
2 other studies available for valproic acid and Lung Adenocarcinoma
| Article | Year |
|---|---|
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer.
Topics: Adenocarcinoma of Lung; Astemizole; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; | 2022 |
Design of enzymatically cleavable prodrugs of a potent platinum-containing anticancer agent.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Humans | 2014 |